CTOs on the Move

Covenant Care

www.covenantcare.com

 
Covenant Care is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Covenant Care is based in Aliso Viejo, CA. You can find more information on Covenant Care at www.covenantcare.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Wesbury United Methodist

Wesbury United Methodist is a Meadville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health Net Medical

Community Health Net offers a range of healthcare services for newborn through geriatric patients.

Medical Education Technologies Inc

Based in Sarasota, Fla., METI is the world's leading manufacturer of high- technology Human Patient Simulators. Its PediaSim(TM) is the first and only pediatric patient simulator in the world.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).